The EBIC Executive Committee signed an agreement with NeuroVive Pharmaceuticals AB to collaborate with regard to the organisation and conduct of an european multicenter clinical trial on NeuroSTAT©. The active ingredient of NeuroSTAT© is cyclosporine-A which is considered a promising neuroprotective agent with a number of putative mechanisms, including mitocondrial protection.
Please fill out the form and submit to EBIC Coordinating Center by the button at the end of this page. * = required field
July 10th - July 13th, 2011 National Neurotrauma Society Annual Meeting Fort Lauderdale, Florida, United States
October 4th - October 14th, 2011 EANS - 14th European Congress of Neurosurgery Palazzo dei Congressi, Rome, Italy